[Tumor-specific gene therapy strategy for renal cell carcinomas]
- PMID: 16523975
[Tumor-specific gene therapy strategy for renal cell carcinomas]
Similar articles
-
Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.Cancer Res. 2006 Jun 15;66(12):6264-70. doi: 10.1158/0008-5472.CAN-05-2519. Cancer Res. 2006. PMID: 16778202
-
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma.Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):680s-684s. doi: 10.1158/1078-0432.CCR-06-1865. Clin Cancer Res. 2007. PMID: 17255293 Review.
-
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.Cancer Res. 2001 Jul 1;61(13):5215-22. Cancer Res. 2001. PMID: 11431362
-
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938. Oncogene. 2000. PMID: 11114720
-
[Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].Zhonghua Bing Li Xue Za Zhi. 2006 Sep;35(9):562-4. Zhonghua Bing Li Xue Za Zhi. 2006. PMID: 17134554 Review. Chinese. No abstract available.
Cited by
-
Efficacy and safety of dendrimer nanoparticles with coexpression of tumor necrosis factor-α and herpes simplex virus thymidine kinase in gene radiotherapy of the human uveal melanoma OCM-1 cell line.Int J Nanomedicine. 2013;8:3805-16. doi: 10.2147/IJN.S48950. Epub 2013 Oct 2. Int J Nanomedicine. 2013. PMID: 24124368 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical